Abstract
BackgroundAnti-nuclear antibodies (ANA) are a hallmark in the diagnosis of systemic autoimmune rheumatic diseases (SARD). Their occurrence in several diseases like systemic lupus erythematodes (SLE), systemic scleroderma, Sjögren’s syndrome, myositis...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
